D-26 | Gender Disparities in Outcomes of Cardiac Procedures with Amyloidosis using the National Inpatient Sample 2016-2019

BackgroundWe aimed to study the gender disparities in outcomes of select cardiac procedures in patients with a secondary diagnosis of amyloidosis.MethodsWe conducted a retrospective analysis using National Inpatient Sample databases 2016 through 2019 for adults aged=>18yrs and admitted for arrhythmia ablation, cardiac resynchronization therapy- pacemaker (CRT-P) or cardiac resynchronization therapy- defibrillator (CRT-D) implantation, dual chamber defibrillator (dc-ICD) implantation, dual chamber pacemaker implantation (dc-PPM), loop recorder (LR) implantation or associated lead placements procedures. International classification of diseases, 10th revision codes were used to identify the study population and data computed with STATA software. The primary outcome was comparing in-hospital mortality while secondary outcomes were procedure utilization rates and discharge disposition status between genders.ResultsA total of 1690 hospitalizations were identified. Mortality was higher in females (Adjusted OR 40.57, CI 9.05-182.02 p <0.05). Higher proportion of males underwent dc-ICD (30.3% vs 19.2%, p<0.05) and CRT-D (12.8% vs 4.8%, p<0.05) implantation. In contrast, more females underwent dc-PPM (34.2% vs 50%, p<0.05) and LR (7.3% vs 15.4%, p<0.05) implantation. Females were less likely to be discharged home (adjusted OR 0.49, CI 0.28-0.85, p <0.05). [Table 1]ConclusionsDisclosuresA. Iyer Nothing to disclose. N. Dewaswala Nothing to disclose. C. Harris Nothing to disclose. H. Bhopalwala Nothing to disclose. R. F. Munshi Nothing to disclose. A. Towheed Nothing to disclose. S. Gupta Nothing to disclose. A. M. Minhas Nothing to disclose. V. N. Gaurang Nothing to disclose. V. Mishra Nothing to disclose. J. B. O'Bryan Nothing to disclose. BackgroundWe aimed to study the gender disparities in outcomes of select cardiac procedures in patients with a secondary diagnosis of amyloidosis. We aimed to study the gender disparities in outcomes of select cardiac procedures in patients with a secondary diagnosis of amyloidosis. MethodsWe conducted a retrospective analysis using National Inpatient Sample databases 2016 through 2019 for adults aged=>18yrs and admitted for arrhythmia ablation, cardiac resynchronization therapy- pacemaker (CRT-P) or cardiac resynchronization therapy- defibrillator (CRT-D) implantation, dual chamber defibrillator (dc-ICD) implantation, dual chamber pacemaker implantation (dc-PPM), loop recorder (LR) implantation or associated lead placements procedures. International classification of diseases, 10th revision codes were used to identify the study population and data computed with STATA software. The primary outcome was comparing in-hospital mortality while secondary outcomes were procedure utilization rates and discharge disposition status between genders. We conducted a retrospective analysis using National Inpatient Sample databases 2016 through 2019 for adults aged=>18yrs and admitted for arrhythmia ablation, cardiac resynchronization therapy- pacemaker (CRT-P) or cardiac resynchronization therapy- defibrillator (CRT-D) implantation, dual chamber defibrillator (dc-ICD) implantation, dual chamber pacemaker implantation (dc-PPM), loop recorder (LR) implantation or associated lead placements procedures. International classification of diseases, 10th revision codes were used to identify the study population and data computed with STATA software. The primary outcome was comparing in-hospital mortality while secondary outcomes were procedure utilization rates and discharge disposition status between genders. ResultsA total of 1690 hospitalizations were identified. Mortality was higher in females (Adjusted OR 40.57, CI 9.05-182.02 p <0.05). Higher proportion of males underwent dc-ICD (30.3% vs 19.2%, p<0.05) and CRT-D (12.8% vs 4.8%, p<0.05) implantation. In contrast, more females underwent dc-PPM (34.2% vs 50%, p<0.05) and LR (7.3% vs 15.4%, p<0.05) implantation. Females were less likely to be discharged home (adjusted OR 0.49, CI 0.28-0.85, p <0.05). [Table 1] A total of 1690 hospitalizations were identified. Mortality was higher in females (Adjusted OR 40.57, CI 9.05-182.02 p <0.05). Higher proportion of males underwent dc-ICD (30.3% vs 19.2%, p<0.05) and CRT-D (12.8% vs 4.8%, p<0.05) implantation. In contrast, more females underwent dc-PPM (34.2% vs 50%, p<0.05) and LR (7.3% vs 15.4%, p<0.05) implantation. Females were less likely to be discharged home (adjusted OR 0.49, CI 0.28-0.85, p <0.05). [Table 1] Conclusions DisclosuresA. Iyer Nothing to disclose. N. Dewaswala Nothing to disclose. C. Harris Nothing to disclose. H. Bhopalwala Nothing to disclose. R. F. Munshi Nothing to disclose. A. Towheed Nothing to disclose. S. Gupta Nothing to disclose. A. M. Minhas Nothing to disclose. V. N. Gaurang Nothing to disclose. V. Mishra Nothing to disclose. J. B. O'Bryan Nothing to disclose. A. Iyer Nothing to disclose. N. Dewaswala Nothing to disclose. C. Harris Nothing to disclose. H. Bhopalwala Nothing to disclose. R. F. Munshi Nothing to disclose. A. Towheed Nothing to disclose. S. Gupta Nothing to disclose. A. M. Minhas Nothing to disclose. V. N. Gaurang Nothing to disclose. V. Mishra Nothing to disclose. J. B. O'Bryan Nothing to disclose.